1700057G04Rik Activators encompass a diverse set of chemical compounds that indirectly induce the functional activity of 1700057G04Rik by modulating various specific signaling pathways. For instance, Forskolin and Isoproterenol, through their action on increasing intracellular cAMP levels, engage PKA activation, which is known to phosphorylate various substrates including potentially 1700057G04Rik, thereby enhancing its activity. Similarly, Insulin and Epidermal Growth Factor (EGF) initiate cascades that activate the PI3K/Akt and MAPK/ERK pathways respectively, leading to subsequent phosphorylation events that may include 1700057G04Rik as a substrate, resulting in its functional enhancement. This gene is part of the mouse genome and is responsible for encoding a protein or RNA with specific cellular roles. To identify these activators, scientists employ a methodological approach that begins with high-throughput screening, a technique designed to assess a multitude of compounds for their ability to modulate gene expression. In such screenings, a luciferase reporter system is often utilized, where the promoter of 1700057G04Rik is linked to the luciferase gene.
Following the preliminary high-throughput screening, compounds earmarked as possible 1700057G04Rik Activators are verified through additional experimental procedures. Quantitative PCR (qPCR) is utilized to measure the levels of 1700057G04Rik mRNA within cells. This method provides a direct quantification of gene expression, confirming that the activators do indeed promote transcription of the 1700057G04Rik gene. Complementary to qPCR, Western blot analysis is implemented to detect and measure the corresponding protein levels. This technique allows for the confirmation that the mRNA transcribed. Moreover, it can identify if the activator influences the protein's stability or its post-translational modifications. Through the integration of qPCR and Western blot findings, a detailed profile of the activator's effect on both the gene and protein expression is established.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA acts as a PKC activator. PKC phosphorylation can lead to activation of downstream signaling pathways that include 1700057G04Rik, enhancing its function. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium concentration, which can activate calmodulin-dependent kinases that may phosphorylate 1700057G04Rik, thereby enhancing its activity. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the PI3K/Akt pathway, which can lead to phosphorylation and activation of downstream proteins including 1700057G04Rik. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates the JNK/SAPK pathway, which may lead to the phosphorylation and consequent activation of 1700057G04Rik. | ||||||
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $116.00 $179.00 $265.00 $369.00 $629.00 $1150.00 | ||
db-cAMP is a cell-permeable cAMP analog that activates PKA. PKA can then phosphorylate and enhance the activity of 1700057G04Rik. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A inhibits protein phosphatases PP1 and PP2A, leading to increased phosphorylation and potential activation of proteins such as 1700057G04Rik. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 acts as a calcium ionophore, raising intracellular calcium levels, which can activate downstream kinases that enhance 1700057G04Rik activity. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a potent inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation of proteins including 1700057G04Rik, thereby enhancing its function. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Br-cAMP is a cAMP analog resistant to degradation. It activates PKA, which could lead to phosphorylation and activation of 1700057G04Rik. | ||||||